Physician profile
Ronnie Chiu
NPI 1700843315
$3,129.45
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,421 · 2020: $433 · 2021: $428 · 2022: $537 · 2023: $173 · 2024: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $935.07 | 2019-2023 | Vemlidy |
| Astrazeneca Pharmaceuticals LP | $853.09 | 2019-2024 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $670.33 | 2019-2022 | |
| Lilly USA, LLC | $311.43 | 2019-2022 | |
| Fresenius Kabi USA, LLC | $99.23 | 2019 | |
| Amgen INC. | $78.07 | 2019-2020 | |
| Amarin Pharma, INC. | $74.08 | 2019 | |
| Radius Health, INC. | $62.14 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $33.64 | 2019 | |
| Nestle Healthcare Nutrition INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronnie Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.